newsfilter
← Latest News
GlobeNewswire·

BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth

BRTX
  • BioRestorative Therapies, Inc. (NASDAQ: BRTX) appointed Zachary Smith as Vice President of its Biocosmeceuticals Division to lead sales channel expansion & pipeline development.
  • Smith will oversee revenue growth across professional aesthetics, regenerative physician channels, strategic partnerships, & key accounts while managing domestic & international sales territories.
  • Lance Alstodt, Chairman & CEO, cited Smith's 16+ years of experience in medical aesthetics & biologics as critical for accelerating the company's commercial expansion.
  • Prior to joining BioRestorative, Smith served as Area Vice President at Cartessa Aesthetics, where he transformed a multi-state region into a top-performing territory.
  • Smith's career includes sales leadership roles at Lumenis Aesthetics & Patterson Companies, with experience managing large healthcare territories across North, Central, & South America.
  • BioRestorative operates a commercial BioCosmeceutical platform featuring cell-based secretome products formulated in a cGMP, ISO-7 certified facility.
  • The company maintains two core clinical development programs: the Disc/Spine Program (BRTX-100 for degenerative disc disease) & the Metabolic Program (ThermoStem using brown adipose stem cells).
  • Smith holds a Bachelor of Science in Finance from Penn State University & a Juris Doctor from Duquesne University School of Law.